Trials / Recruiting
RecruitingNCT06813573
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to prospectively follow the level of circulating nucleosomes in patients treated for a non-Hodgkin lymphoma and determine whether it correlates with the clinical response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | blood sampling | A maximum of 4 tubes of 10ml will be collected: at baseline (before cycle 1), before each cycle (from 2 to 6 included), at the end of the treatment, and in case of relapse during follow-up period |
Timeline
- Start date
- 2024-09-30
- Primary completion
- 2028-10-01
- Completion
- 2029-10-01
- First posted
- 2025-02-07
- Last updated
- 2025-02-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06813573. Inclusion in this directory is not an endorsement.